Inventor · disambiguated record
Gregoire Prevost
Also filed as: PREVOST GREGOIRE
15 granted patents·20 pending applications·54 citations·filing 1999–2010
90Inventor score
Top patents by PatentIndex Score
35 records- 0181US8017637B2Inhibitors of cdc phosphatasesIPSEN PHARMA SAS·Filed 2005·Granted Sep 13, 2011·9 cites·24 claims
- 0281US7795284B24,7-dioxobenzothiazole-2-carboxamide derivatives, their preparation and their therapeutic usesIPSEN PHARMA SAS·Filed 2005·Granted Sep 14, 2010·9 cites·12 claims
- 0381US7279467B2Benzothiazole-and benzoxazole-4, 7-dione derivatives and their use as dcd25 phosphatase inhibitorsSOD CONSEILS RECH APPLIC·Filed 2002·Granted Oct 9, 2007·12 cites·3 claims
- 0480US7495021B2Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitorsSOD CONSEILS RECH APPLIC·Filed 2007·Granted Feb 24, 2009·3 cites·16 claims
- 0579US8188133B2Imidazole derivatives, preparation and user thereof as medicineLIBERATORE ANNE-MARIE·Filed 2007·Granted May 29, 2012·7 cites·9 claims
- 0672US2009270341A1Product comprising a transduction inhibitor of heterotrimeric g protein signals combined with another anti-cancer agent for therapeutic use in the treatment of cancerIPSEN PHARMA SAS·Filed 2009·Application pending·0 cites
- 0770US8624037B2Imidazolidine-2,4-dione derivatives and use thereof as a medicamentBIGG DENNIS·Filed 2010·Granted Jan 7, 2014·2 cites·23 claims
- 0870US7034024B1Product inhibiting transduction of G heterotrimeric protein signals combined with another anti-cancer agent for therapeutic use in cancer treatmentSOD CONSEILS RECH APPLIC·Filed 2000·Granted Apr 25, 2006·2 cites·2 claims
- 0966US6846822B2Product comprising a heterotrimeric G protein signal transduction inhibitor associated with anti-hypertensive agent for therapeutic use in the treatment of arterial hypertensionSOD CONSEILS RECH APPLIC·Filed 2001·Granted Jan 25, 2005·3 cites·20 claims
- 1061US2006074078A1Product comprising a transduction inhibitor of heterotrimeric G protein signals combined with another anti-cancer agent for therapeutic use in the treatment of cancerSCRAS·Filed 2005·Application pending·0 cites
- 1160US2009137596A1G-protein inhibitorSOD CONSEILS RECH APPLIC·Filed 2008·Application pending·0 cites
- 1259US2009131428A1Benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitorsSOD CONSEILS RECH APPLIC·Filed 2008·Application pending·0 cites
- 1359US2009082345A1Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitorsSOD CONSEILS RECH APPLIC·Filed 2008·Application pending·0 cites
- 1457US7132553B2Product comprising an inhibitor of the transduction of heterotrimeric G protein signals combined with an anti-hypertensive agent for therapeutic use in the treatment of arterial hypertensionSOD CONSEILS RECH APPLIC·Filed 2004·Granted Nov 7, 2006·0 cites·20 claims
- 1556US7196084B2Cdc25 phosphatase inhibitorsSOD CONSEILS RECH APPLIC·Filed 2001·Granted Mar 27, 2007·1 cites·9 claims
- 1656US2007255063A1Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitorsSOD CONSEILS RECH APPLIC·Filed 2007·Application pending·0 cites
- 1755US6767561B2DNA polymerase inhibitors, mikanolide and dihydromikanolideSOD CONSEILS RECH APPLIC·Filed 2000·Granted Jul 27, 2004·1 cites·11 claims
- 1853US2008161253A1Composition for the treatment of nasopharyngeal carcinoma and method of use thereofPREVOST GREGOIRE·Filed 2008·Application pending·0 cites
- 1952US2006281736A1Product comprising at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agentPREVOST GREGOIRE·Filed 2004·Application pending·0 cites
- 2051US2006035899A1Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G proteinSCRAS·Filed 2005·Application pending·0 cites
- 2150US2009270400A1Painkilling association comprising a dihydroimidazopyrazine derivativeSOD CONSEILS RECH APPLIC·Filed 2005·Application pending·0 cites
- 2250US2006154933A1Inhibitors of Cdc25 phosphatasesSCRAS·Filed 2006·Application pending·0 cites
- 2350US2009270401A1Use of a dihydroimidazopyrazoine derivative for treating or preventing painSOD CONSEILS RECH APPLIC·Filed 2005·Application pending·0 cites
- 2449US7034025B2Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G proteinSOD CONSEILS RECH APPLIC·Filed 2003·Granted Apr 25, 2006·0 cites·5 claims
- 2549US2010222332A1Pyrazolo-pyrazines derivatives used as g protein inhibitorsIPSEN PHARMA SAS·Filed 2008·Application pending·0 cites
- 2649US2006235027A1Inhibitors of cdc25 phosphatasesSCRAS·Filed 2006·Application pending·0 cites
- 2748US7091239B2DNA polymerase inhibitors, mikanolide and dihydromikanolideSOD CONSEILS RECH APPLIC·Filed 2004·Granted Aug 15, 2006·0 cites·4 claims
- 2847US2006166907A1Composition for the treatment of nasopharyngeal carcinoma and method of use thereofPREVOST GREGOIRE·Filed 2003·Application pending·0 cites
- 2946US2004259834A1Therapeutic composition containing at least diflomotecan and capecitabineFiled 2003·Application pending·0 cites
- 3043US6544995B1Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric G proteinSOD CONSEILS RECH APPLIC·Filed 1999·Granted Apr 8, 2003·5 cites·6 claims
- 3139US6887869B2Mikanolide derivatives, their preparation and therapeutic usesSOD CONSEILS RECH APPLIC·Filed 2002·Granted May 3, 2005·0 cites·13 claims
- 3239US2010317658A14,7-Dioxobenzothiazole-2-Carboxamide Derivatives, Their Preparation And Their Therapeutic UsesIPSEN PHARMA SAS·Filed 2010·Application pending·0 cites
- 3339US2004138245A1Product comprising mikanolide, dihydromikanolide or an analogue thereof combine with another anti-cancer agent for therapeutic use in cancer treatmentPREVOST GREGOIRE·Filed 2002·Application pending·0 cites
- 3438US2004048849A1Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitorsFiled 2001·Application pending·0 cites
- 3527US2004029204A1Method for obtaining human cdc25 phosphatases and method for identifying human cdc25 phosphatase modulatorsFiled 2000·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gregoire Prevost files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →